This research was undertaken to identify the cell surface receptor responsible for mediating apolipoprotein (apo) E inhibition of PDGF-directed smooth muscle cell migration.
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The importance of apolipoprotein (apo) E in vascular protection has been recognized for a number of years (1, 2) . Aside from its well-documented function in mediating lipoprotein clearance by the liver (3), recent evidence suggests that apoE also has direct cell regulatory functions in manners that are protective against vascular disease (4, 5) . These include the modulation of inflammatory response by suppressing lymphocyte activation (6, 7) , inhibiting agonist-induced platelet aggregation and activation (8, 9) , and suppressing growth factor-induced smooth muscle cell migration and proliferation (10, 11) . ApoE is also present in the brain and the central nervous system where it participates in neurite outgrowth and nerve regeneration (12, 13) .
These diverse functions of apoE may possibly be attributed to its ability to bind several different receptors on cell surface membranes.
The initial step of apoE mediated cholesterol transport is its binding to the LDL receptor on the cell surface (14) . Subsequent steps include endocytosis of the apoE-containing lipoproteins, their transport to lysosomes where lipoprotein degradation takes place.
Unesterified cholesterol liberated from lysosomal degradation of lipoproteins can then be used for maintenance of cellular cholesterol homeostasis (14) . The LDL receptor is located in clathrin coated pits and its rapid endocytosis is mediated through the NPXY motif on the cytoplasmic tail of the protein (15) . In the absence of a functional LDL receptor, apoE interaction with the LDL receptor-related protein (LRP) may also deliver cholesterol to cells through a similar endocytosis/lysosomal processing mechanism (16) (17) (18) (19) (20) . In contrast to the LDL receptor, the two NPXY motifs within the cytoplasmic tail of LRP play only a minimal role in endocytosis (21) .
The dominant endocytosis signal in LRP is conferred by a YXXL motif and a di-leucine sequence (21) . The initial step of apoE modulation of cell functions is also mediated by its binding to the cell surface. Previous studies have shown that apoE and immunoregulatory LDL suppress lymphocyte activation via binding to cell surface receptors, but endocytosis is not a prerequisite (6, 22, 23) . Although the immunosuppressive apoE receptor has not been identified to date, it is quite clear that the LDL receptor is not involved (24) . ApoE stimulation of neurite outgrowth is also independent of the LDL receptor, and is mediated by apoE interaction with LRP (13, 25) .
Importantly, both immunosuppression and stimulation of neurite outgrowth by apoE are unrelated to its cholesterol transporting properties as minimally lipidated or delipidated apoE are equally active in regulating these lymphocyte and neuronal cell functions (6, 22, 26) . In contrast, apoE inhibition of platelet aggregation requires its presence in a lipoprotein form (9) . Nevertheless, the LDL receptor does not appear to play a role in apoE inhibition of platelet aggregation (8) . ApoE inhibition of platelet aggregation is also unrelated to its cholesterol transport function (8) , but has been suggested to be mediated through binding to another member of the LDL receptor gene family, the apoE receptor 2 (apoER2), on the platelet membrane (8, 27) and the induction of nitric oxide synthesis (9) .
The mechanism by which apoE inhibits smooth muscle cell migration and proliferation is also attributed to its ability to modulate cell signaling events (10, 11) . Previously, we showed that apoE inhibits growth factor-induced smooth muscle cell migration and proliferation via inhibition of mitogen activated protein kinase and induction of cyclin D1 expression (10) .
Moreover, apoE inhibition of smooth muscle cell proliferation, but not their migration, appears to be mediated by stimulation of nitric oxide synthase (11) . The latter observation suggested that by guest on http://www.jbc.org/ Downloaded from 5 apoE inhibits smooth muscle cell migration and proliferation through different mechanisms. Our recent data confirmed this hypothesis and revealed that apoE inhibition of smooth muscle cell proliferation is mediated through its binding to heparan sulfate proteoglycans, while its inhibition of cell migration is mediated through binding to cell surface receptors. While the heparan sulfate proteoglycan perlecan has been implicated as a mediator for apoE inhibition of cell proliferation (28) , the identity of the cell surface receptor responsible for apoE inhibition of smooth muscle cell migration remains elusive. The goal of this study is to identify the receptor involved. . Antibodies against LRP were generated against purified human placental LRP as described (29) . The anti-LRP IgG was characterized previously and shown to inhibit apoE binding to LRP on mammalian cells (13, 25) . The hybridoma cell line IgG-11H4 that secretes mouse monoclonal antibodies against the carboxyl terminus of LRP (30) was obtained from ATCC (Manassas, Virginia). These hybridoma cells were originally produced in the Brown and Goldstein laboratory and were characterized previously (30) . Morpholino-derivatized oligonucleotides were purchased from Gene Tools (Corvallis, OR).
Isolation of Mouse Aortic Smooth
Muscle Cells -Aortic smooth muscle cells were isolated from either C57BL/6 wild type mice, or mice that are defective in LDL receptor, VLDL receptor, or apoE receptor-2 gene expression. All the animals were obtained from Jackson Laboratories (Bar Harbor, ME), except the apoE receptor-2 knockout mice which were the gift of Dr. Joachim Herz at the University of Texas Southwestern Medical School. Aortic smooth muscle cells were isolated using a modification of Mimura's procedure (31) and characterized as described previously (32). The primary aortic smooth muscle cells were cultured in DMEM containing 10% fetal bovine serum, 100 units/ml penicillin, and 0.1 mg/ml streptomycin. Cells between passages 1 and 5 were used for experiments. Maximum cell migration was determined as the number of cells migrated toward PDGF at the bottom of the Transwell chamber when incubation was carried out in the absence of apoE. All experiments were performed in triplicates and were repeated at least three times.
Apolipoprotein E Isolation -Human apoE was isolated from pooled fresh plasma obtained from healthy volunteers by the method of Cardin et al. (39) . The purity of apoE was assessed by SDSpolyacrylamide gel electrophoresis. Samples containing a single band with Mr=34,000 were used. The purified apoE was stored as lyophilized sample at -80 °C, and was resuspended in
RESULTS
Previous studies have reported the presence of the LDL receptor, LRP, VLDL receptor, and apoE receptor-2 on human, rabbit, and rat smooth muscle cells (40-42). The presence of these LDL receptor family members on mouse aortic smooth muscle cells was verified by RT-PCR amplification of their RNA (Fig. 1) . Since a common characteristic of LDL receptor family members is their ability to bind apoE, one or more of these receptors may mediate apoE inhibition of smooth muscle cell migration in response to growth factor stimulation. (Fig. 2) . These results documented that apoE inhibition of smooth muscle cell migration is not due to its binding to the LDL receptor.
Similar approach was used to assess the role of the VLDL receptor and apoE receptor-2 on apoE inhibition of smooth muscle cell migration. Smooth muscle cells isolated from VLDLR -/-mice and from apoE receptor-2-negative mice were similar to cells from wild type mice in their responsive to apoE inhibition of smooth muscle cell migration (Fig. 3) . Thus, neither the VLDL receptor nor the apoE receptor-2 was responsible for this apoE effect. The role of LRP in mediating apoE inhibition of smooth muscle cell response to PDGF cannot be addressed using similar approach due to the lethality of the LRP -/-mice. To circumvent this problem, an antisense receptor knockdown approach was used to produce LRP deficient smooth muscle cells. An antisense oligonucleotide 5'-CCTCTGGTCCTGTTACTTCTTGTCC-3', which is complementary to LRP mRNA residues 386-410, was synthesized for these experiments. The oligonucleotide was modified by morpholino linkage to increase solubility and to provide highly specific antisense activity in transfected cells (43) . The incubation of primary smooth muscle cells with this morpholinoderivatized antisense LRP oligonucleotide resulted in cells that were defective in expression of LRP (Fig. 4) . As a control, cells incubated with a random sequence oligonucleotide had no effect on LRP expression (Fig. 4) . The random morpholino-oligonucleotide also had no effect on the subsequent ability of the cells to migrate toward PDGF (Fig. 5) . In contrast, preincubating the smooth muscle cells with the morpholino-derivatized antisense LRP oligonucleotide significantly abrogated the apoE effect on suppression of PDGF-directed smooth muscle cell migration (Fig. 5) . The ability of the antisense LRP oligonucleotide to suppress apoE inhibition of cell migration in each experiment correlated well with its effect on LRP expression (Fig. 5) . These data strongly suggest that LRP is the cell surface receptor that mediates apoE inhibition of smooth muscle cell migration.
Additional experiments using a different approach were used to confirm the role of LRP in mediating apoE inhibition of cell migration. Polyclonal antibodies that were shown previously to inhibit apoE binding to LRP (13, 25) were used in these experiments. The results of these studies showed that anti-LRP antibodies alone have no direct effect on PDGF-stimulated 12 smooth muscle cell migration (Fig. 6) . However, the anti-LRP antibodies significantly alleviated apoE inhibition of smooth muscle cell migration toward PDGF (Fig. 6) . be noted that anti-LRP alone had no effect on PDGF-stimulated cell migration in our study, while anti-LRP was reported to inhibit uPA-stimulated cell migration (44) . The difference between our results and those reported earlier is unclear, but may be related to differences between uPA and PDGF in mechanism of stimulation of cell migration, or to the reactivity differences between the two anti-LRP antibodies used in the respective experiments.
It is interesting to note that LRP binding to either apoE (current study) or RAP (44) resulted in inhibition of agonist-induced smooth muscle cell migration. These results suggest that occupancy of the extracellular domain of LRP is sufficient to confer resistance to agonistinduced smooth muscle cell migration. While the mechanism by which ligand binding to LRP results in inhibition of smooth muscle cell migration remains unclear at this time, the data add to an expanding literature that suggests LRP may mediate signal transduction events in addition to its role as an endocytosis receptor protein (50, 51) . Recently, yeast two-hybrid assays revealed LRP interaction with an extensive set of cytoplasmic adaptor or scaffold proteins in the brain (52) . In addition, LRP has also been shown to be tyrosine phosphorylated, possibly at one or both of its NPXY domains, and LRP phosphorylatioin results in its interaction with the 
ACKNOWLEDGMENTS
The authors thank Dr. Joachim Herz for making the apoE receptor-2 knockout mice available for the isolation of receptor-deficient smooth muscle cells. We also appreciate the excellent technical assistance from Tara Riddle and Josh Basford. Cells that migrated to the lower surface of the membranes were counted in different high power by guest on September 1, 2017
FOOTNOTES

